❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Cancer Immunology ❭ Cell Signaling and Immune Regulation [Taskén] ❭
Page visits: 1
Scroll to top

Home Dept. of Cancer Immunology Cell Signaling and Immune Regulation [Taskén]

  • Group members
  • Research
  • Group Achievements
  • Publications
  • Gallery
  • News and Vacancies
  • Sigrid Skånland's project group

Recent publications

Yin Y, Xu H, He L, Brown JR, Mato AR, Aittokallio T, Skånland SS (2025)
Protein profiles predict treatment responses to the PI3K inhibitor umbralisib in patients with chronic lymphocytic leukemia
Clin Cancer Res (in press)
DOI 10.1158/1078-0432.CCR-24-2911, PubMed 40085050

Taskén K, Mahon P (2025)
Accelerating precision oncology by converging pragmatic trials and real-world evidence
Nat Rev Drug Discov (in press)
DOI 10.1038/d41573-025-00047-5, PubMed 40082591

Kelly MP, Nikolaev VO, Gobejishvili L, Lugnier C, Hesslinger C, Nickolaus P, Kass DA, Pereira de Vasconcelos W, Fischmeister R, Brocke S, Epstein PM, Piazza GA, Keeton AB, Zhou G, Abdel-Halim M, Abadi AH, Baillie GS, Giembycz MA, Bolger G, Snyder G, Tasken K, Saidu NEB, Schmidt M, Zaccolo M, Schermuly RT et al. (2025)
Cyclic nucleotide phosphodiesterases as drug targets
Pharmacol Rev, 77 (3), 100042 (in press)
DOI 10.1016/j.pharmr.2025.100042, PubMed 40081105

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)